Frontiers in Bioengineering and Biotechnology（生物工程和生物技术前沿杂志）影响因子_期刊投稿发表

期刊简介

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

将医学上的新发现转化为临床常规工作从来都不容易。在上个世纪后半叶，由于化学、生物化学和药理学的进步，我们看到了大量药物和装置的开发和应用，这些药物和装置旨在治疗症状，阻断不必要的途径，并在传染病的情况下，与致病微生物作斗争。然而，我们今天面临着病理和疾病治疗方法的巨大变化。实际上，当前和下一个十年的挑战是完全恢复患病生物体的生理状态，并在组织和器官受到严重影响时完全再生组织和器官，使得治疗不能局限于抑制症状或修复损伤。这是由于基础细胞和分子生物学的重大发展，包括干细胞科学、生长因子递送、基因分离和转染，生物工程和纳米技术的进步，包括新生物材料的开发、生物制造技术和生物反应器的使用，以及诊断工具和细胞、组织和器官成像的重大改进。加强多学科专家之间的交流，以及促进科学家、工程师、工业人员、管理机构和医生之间的联合项目和密切合作，是开发和临床应用新的生物疗法或涉及生物材料、细胞和/或生物活性分子的集体使用的创新装置的任何尝试成功的绝对要求。“生物工程和生物技术前沿”希望成为所有参与这一进程的人的论坛，弥合基础科学发现与其临床应用之间经常存在的差距。

《Frontiers in Bioengineering and Biotechnology》期刊已被查看：次

分区信息